SecBot SecBot

PPBT

PURPLE BIOTECH LTD.
Nasdaq· Pharmaceutical Preparations· Inc. L3· CIK 0001614744 Biotech & Drug Discovery
$1.68 +0.05 (+3.07%)
Nov 16 4:00 PM ET · prev $1.63
Market cap
$2.6M
Nano cap
Median target
$17.00
+912% · range $17.00–17.00
1 year
−76.7%
from $7.20 · Nov 17
30 days
+55.6%
from $1.08
52-week range
$0.9240–8.74
−81% from high · low Oct 27
Avg volume 20D
30.9K
shares / day
Short interest
15.7K
≈1.0% of shares · −3.8%
Days to cover
1.0
at average volume
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read MIXED 7 reports · 90 days
Balance 0 bearish · 0 bullish · 7 neutral oldest → newest, height = score
Avg score ·High conf. 6/7

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q3 2026: 2 added (0 new), 0 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.420 → −$2.880 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −3.8% to 15.7K shares. 1.0 days to cover, ≈1.0% of shares.

  • TrendUPTREND

    21% above its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED6,472$9.8K
MORGAN STANLEYADD300$456.00
ROYAL BANK OF CANADADOUBLED128Not reported
SUSQUEHANNA INTERNATIONAL GROUP, LLPNEAR_EXIT12,847$21.6K
UBS Group AGDOUBLED751$1.3K
MORGAN STANLEYTRIM197$331.00
BNP PARIBAS FINANCIAL MARKETSADD21,075$13.9K
SIMPLEX TRADING, LLCDOUBLED9,231$6.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Aug 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +912%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Aug 7, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
−$2.88
EPS estimate, this quarter
−586%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$2.88-$2.88–-$2.88-66.5%$0.00
Next Q-$3.00-$3.00–-$3.00-19.5%$0.00
Current FY-$5.73-$5.73–-$5.73-7.9%$0.00
Next FY-$1.01-$1.01–-$1.01-14.8%$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 30, 2026
15,729
shares short
-3.8%
vs prior settlement
1.0
days to cover
≈1.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.

SecBot reports

11 filings · 3 press releases · 1 bullish · 0 bearish · 10 neutral
All PPBT filing & press-release reports (14)